Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.


Autoria(s): Bonnier G.; Roche A.; Romascano D.; Simioni S.; Meskaldji D.; Rotzinger D.; Lin Y.C.; Menegaz G.; Schluep M.; Du Pasquier R.; Sumpf T.J.; Frahm J.; Thiran J.P.; Krueger G.; Granziera C.
Data(s)

01/06/2014

Resumo

INTRODUCTION: In patients with multiple sclerosis (MS), conventional magnetic resonance imaging (MRI) provides only limited insights into the nature of brain damage with modest clinic-radiological correlation. In this study, we applied recent advances in MRI techniques to study brain microstructural alterations in early relapsing-remitting MS (RRMS) patients with minor deficits. Further, we investigated the potential use of advanced MRI to predict functional performances in these patients. METHODS: Brain relaxometry (T1, T2, T2*) and magnetization transfer MRI were performed at 3T in 36 RRMS patients and 18 healthy controls (HC). Multicontrast analysis was used to assess for microstructural alterations in normal-appearing (NA) tissue and lesions. A generalized linear model was computed to predict clinical performance in patients using multicontrast MRI data, conventional MRI measures as well as demographic and behavioral data as covariates. RESULTS: Quantitative T2 and T2* relaxometry were significantly increased in temporal normal-appearing white matter (NAWM) of patients compared to HC, indicating subtle microedema (P = 0.03 and 0.004). Furthermore, significant T1 and magnetization transfer ratio (MTR) variations in lesions (mean T1 z-score: 4.42 and mean MTR z-score: -4.09) suggested substantial tissue loss. Combinations of multicontrast and conventional MRI data significantly predicted cognitive fatigue (P = 0.01, Adj-R (2) = 0.4), attention (P = 0.0005, Adj-R (2) = 0.6), and disability (P = 0.03, Adj-R (2) = 0.4). CONCLUSION: Advanced MRI techniques at 3T, unraveled the nature of brain tissue damage in early MS and substantially improved clinical-radiological correlations in patients with minor deficits, as compared to conventional measures of disease.

Identificador

https://serval.unil.ch/?id=serval:BIB_CA5C2B672057

isbn:2328-9503 (Electronic)

pmid:25356412

doi:10.1002/acn3.68

http://my.unil.ch/serval/document/BIB_CA5C2B672057.pdf

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_CA5C2B6720570

Idioma(s)

en

Direitos

info:eu-repo/semantics/openAccess

Fonte

Annals of Clinical and Translational Neurology, vol. 1, no. 6, pp. 423-432

Tipo

info:eu-repo/semantics/article

article